£490.00

It has never been this cheap. We have no record of a lower price.

£490 today · cheaper than every other day in the last 3 months

Renin-Angiotensin System-Blocking Drug Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 25 days · 25 data points (no recent data)

Historical
Generating forecast…
£490.00 £465.50 £475.30 £485.10 £494.90 £504.70 £514.50 03 August 2026 09 August 2026 15 August 2026 21 August 2026 27 August 2026
View at Amazon ↗

Price data last checked 66 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 25 days • 1 price levels

Days at Price
25 days 0 6 13 19 25 £490 Days at Price

Price Analysis

Most common price: £490 (25 days, 100.0%)

Price range: £490 - £490

Price levels: 1 different prices over 25 days

Description

This market study provides a detailed outlook for renin-angiotensin system-blocking cardiovascular drugs from 2023 to 2028. It focuses on latent demand across the United States, offering potential industry earnings (P.I.E.) estimates for 10,833 specific zip codes. By providing data at the zip code level, this report helps professionals understand market opportunities within individual states and throughout the entire country. The report includes comparative benchmarks that show the percent share of each zip code relative to its state and the total U.S. market. This statistical approach allows for quick comparisons, making it a useful tool for distribution and market analysis. Gain a clear view of cardiovascular drug demand trends across the United States through this comprehensive data set.

Key Features

Provides latent demand estimates for renin-angiotensin system-blocking cardiovascular drugs across 10,833 U.S. zip codes.

Includes potential industry earnings (P.I.E.) data to help identify market opportunities through 2028.

Offers comparative benchmarks showing the percent share of each zip code relative to its state and the United States.

Delivers detailed statistical analysis designed to assist with distribution and market planning strategies.

Covers a comprehensive outlook period spanning from 2023 to 2028 for the cardiovascular drug industry.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 January 2023
Listed Since
27 January 2023

Similar Products You Might Like

The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in China
99% match

The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in China

£495.00 02 Oct 2026
The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in Japan
99% match

The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in Japan

£495.00 25 Aug 2026
Renin-Angiotensin System-Blocking Drug Outlook 2023-2028
99% match

Renin-Angiotensin System-Blocking Drug Outlook 2023-2028

£520.00 03 Sep 2026
The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in India
98% match

The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in India

£515.00 25 Aug 2026
US Anti-Hypertensive Diuretic Drug Outlook 2023-2028
97% match

US Anti-Hypertensive Diuretic Drug Outlook 2023-2028

£490.00 26 Aug 2026
The 2013-2018 Outlook for Anti-Hypertensive Drugs in India
96% match

The 2013-2018 Outlook for Anti-Hypertensive Drugs in India

£495.00 15 Aug 2026
The 2025-2030 World Outlook for Aldosterone-Antagonist Dilated Cardiomyopathy Therapeutics
96% match

The 2025-2030 World Outlook for Aldosterone-Antagonist Dilated Cardiomyopathy Therapeutics

£790.00 21 Aug 2026
The 2021-2026 World Outlook for Antihypertensive Drugs
96% match

The 2021-2026 World Outlook for Antihypertensive Drugs

£795.00 29 Oct 2026
The 2021-2026 World Outlook for Ace Inhibitor Vasodilator Pharmaceuticals
96% match

The 2021-2026 World Outlook for Ace Inhibitor Vasodilator Pharmaceuticals

£795.00 26 Sep 2026
Blood Pressure Monitoring Outlook 2023-2028 US Zip Codes
96% match

Blood Pressure Monitoring Outlook 2023-2028 US Zip Codes

£490.00 08 Sep 2026
The 2016-2021 Outlook for Ace Inhibitor Vasodilator Pharmaceuticals in Japan
96% match

The 2016-2021 Outlook for Ace Inhibitor Vasodilator Pharmaceuticals in Japan

£595.00 03 Sep 2026
The 2016-2021 World Outlook for Anti-Hypertensive Drugs
96% match

The 2016-2021 World Outlook for Anti-Hypertensive Drugs

£995.00 31 Oct 2026
The 2013-2018 Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals in India
96% match

The 2013-2018 Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals in India

£495.00 15 Aug 2026
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in Japan
96% match

The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in Japan

£495.00 22 Aug 2026
The 2013-2018 Outlook for Thiazides and Related Diuretic Agents in India
96% match

The 2013-2018 Outlook for Thiazides and Related Diuretic Agents in India

£495.00 29 Aug 2026
The 2021-2026 World Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals
96% match

The 2021-2026 World Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals

£795.00 01 Nov 2026
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in China
96% match

The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in China

£495.00 20 Aug 2026
Heart Failure Drugs US Zip Code Outlook 2023-2028 Study
96% match

Heart Failure Drugs US Zip Code Outlook 2023-2028 Study

£490.00 22 Aug 2026
The 2013-2018 Outlook for Coronary Vasodilator Pharmaceuticals in India
96% match

The 2013-2018 Outlook for Coronary Vasodilator Pharmaceuticals in India

£495.00 29 Oct 2026
Anticoagulant Reversal Drugs Outlook 2023-2028 US Zip Codes
96% match

Anticoagulant Reversal Drugs Outlook 2023-2028 US Zip Codes

£490.00 28 Oct 2026
The 2016-2021 Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals in Japan
96% match

The 2016-2021 Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals in Japan

£595.00 23 Aug 2026
The 2016-2021 Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals in Greater China
96% match

The 2016-2021 Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals in Greater China

£595.00 24 Sep 2026
The 2023-2028 Outlook for Percutaneous Coronary Interventions for US Zip Codes
96% match

The 2023-2028 Outlook for Percutaneous Coronary Interventions for US Zip Codes

£490.00 11 Oct 2026
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in India
96% match

The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in India

£515.00 26 Aug 2026